Salvage Resuscitation in Severe Trauma: When to Stop or Continue

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Traumatic cardiac arrest is distinct from medical arrest, stemming from circulatory failure (hemorrhage, obstruction, tension physiology) rather than primary electrical disease, necessitating hemorrhage control as the primary salvage intervention.
• Salvage resuscitation hinges on the oxygen debt model, where restoring blood pressure alone is insufficient if oxygen debt persists; clinicians must assess the duration and depth of ischemic insult, not just arrest duration.
• Advanced interventions like resuscitative thoracotomy and REBOA require residual cardiac activity to be effective and are primarily indicated for witnessed arrests with reversible causes or non-compressible torso hemorrhage, respectively.
• Futility in salvage resuscitation is a probabilistic assessment based on arrest duration, rhythm, injury pattern, response to initial resuscitation, and available resources, guiding the ethical decision to cease efforts and avoid prolonging suffering.
• Key monitoring parameters for guiding salvage decisions include end-tidal carbon dioxide (EtCO₂) trends (persistently <10 mmHg after 15 minutes suggests futility), cardiac rhythm, pulse quality, pupillary light response, and lactate trends.
• Recognized complications of salvage resuscitation include reperfusion injury (manifesting as hyperkalemia, acidosis, myocardial depression), coagulopathy, and ongoing hemorrhage, requiring vigilant monitoring and prompt management.

This article addresses the decision framework for salvage interventions in canine and feline trauma patients, focusing on when resuscitative efforts remain rational and when they become futile. It serves the practicing veterinarian who has completed the primary survey, initiated immediate stabilization, and now faces the question of whether to escalate to resuscitative thoracotomy, pursue endovascular occlusion, or stop. The clinical question is procedural: which findings justify continued intervention, which findings mandate cessation, and how should the clinician weigh survival probability against the ethical obligation to avoid prolonging suffering.

The content assumes familiarity with trauma triage, shock physiology, and standard fluid therapy. It does not repeat those foundations. Instead, it builds on them to examine the physiology of traumatic cardiac arrest, the technique principles of aortic occlusion, and the evidence base for salvage interventions. The later sections of this four-part article will provide practical decision criteria, monitoring parameters, and communication frameworks for the euthanasia decision.

At a Glance

Physiology of Traumatic Cardiac Arrest

Traumatic cardiac arrest differs fundamentally from primary cardiac arrest. In medical arrest, the heart fails and the circulation stops secondarily. In trauma, the circulation fails first, through hemorrhage, obstruction, or tension physiology, and the heart arrests as a consequence of profound hypoperfusion and hypoxia. This distinction matters for resuscitation strategy. The myocardium in traumatic arrest is often structurally normal, and the arrest is a manifestation of reversible perfusion failure instead of primary electrical disease.

The RECOVER Initiative guidelines distinguish between arrest types and emphasize that traumatic arrest carries a different prognosis and different therapeutic priorities than medical arrest. The guidelines note that conventional CPR alone rarely restores circulation in exsanguinating trauma because the problem is loss of circulating volume, not pump failure. Effective salvage therefore requires hemorrhage control as the primary intervention, with CPR as a supportive measure to maintain coronary and cerebral perfusion while control is achieved.

The ischemic tolerance of tissues defines the time window for salvage. The brain tolerates approximately 4 to 6 minutes of complete ischemia before irreversible injury begins, while the myocardium tolerates slightly longer. In hemorrhagic shock, however, the ischemic insult is progressive instead of abrupt, and the duration of hypotension before arrest influences outcome more than the duration of arrest itself. A patient that has been hypotensive for 30 minutes before arrest has exhausted compensatory mechanisms and tissue oxygen debt, whereas a patient that arrests suddenly after a witnessed penetrating injury may retain significant salvage potential.

The Oxygen Debt Model

The conceptual foundation for salvage resuscitation is the oxygen debt model. Hemorrhage reduces oxygen delivery, and the body compensates through increased extraction, tachycardia, and vasoconstriction. When delivery falls below the critical threshold, oxygen consumption becomes supply-dependent, and an oxygen debt accumulates. The debt is the difference between the oxygen required for aerobic metabolism and the oxygen actually delivered. This debt correlates with the severity of shock and predicts the risk of multiple organ failure and death.

Resuscitation aims to repay this debt, also to restore blood pressure. A patient that achieves normal blood pressure but remains in oxygen debt continues to accumulate cellular injury. This explains why some trauma patients deteriorate hours after apparently successful initial resuscitation. The clinician assessing salvage potential must therefore consider also the current hemodynamic state but also the estimated duration and depth of the ischemic insult.

The oxygen debt model also explains the reperfusion injury that follows successful hemorrhage control. When blood flow is restored to ischemic tissues, the reintroduction of oxygen triggers an inflammatory cascade that can cause further cellular damage. This is particularly relevant to aortic occlusion techniques, which create deliberate ischemia in caudal tissue beds to preserve perfusion to the heart and brain. The review of resuscitative endovascular balloon occlusion of the aorta describes this trade-off explicitly: occlusion controls hemorrhage and augments cranial blood pressure while exposing caudal beds to ischemia and the whole body to reperfusion injury.

Aortic Occlusion as a Salvage Strategy

Resuscitative thoracotomy with aortic cross-clamping has been the traditional salvage intervention for non-compressible torso hemorrhage. The technique redirects the remaining cardiac output to the coronary and cerebral circulations while reducing blood loss below the clamp. Its success depends on the presence of some residual cardiac output. In a patient with established asystole, aortic cross-clamping alone cannot restore circulation because there is no flow to redirect.

Resuscitative endovascular balloon occlusion of the aorta, or REBOA, achieves the same physiologic effect through a percutaneously placed balloon catheter. The veterinary applications of REBOA have been reviewed in the context of human trauma literature and translational large animal studies. Zone 1 occlusion, at the thoracic aorta, controls subdiaphragmatic hemorrhage and augments pressure to the heart and brain. Zone 3 occlusion, at the infrarenal aorta, controls pelvic and hindlimb hemorrhage with less ischemic burden.

The critical limitation of REBOA is the same as aortic cross-clamping: it requires intrinsic cardiac activity to be effective. The translational swine model comparing selective aortic arch perfusion and REBOA demonstrated that REBOA alone could not achieve return of spontaneous circulation once electrocardiographic asystole had occurred. The study found that selective aortic arch perfusion, which combines balloon occlusion with oxygenated intra-aortic perfusion, was superior for achieving ROSC in hemorrhage-induced traumatic cardiac arrest. This finding has direct relevance to veterinary decision-making: a trauma patient in established asystole is unlikely to benefit from aortic occlusion alone, and the clinician should consider whether more advanced perfusion techniques are available, which in most veterinary settings they are not.

The Ischemia-Reperfusion Trade-Off

Every salvage intervention that restores perfusion creates an ischemia-reperfusion burden. The clinician must weigh the immediate survival benefit against the downstream costs of reperfusion injury. This is also a theoretical concern. The review of clostridial myonecrosis illustrates the extreme end of this spectrum, where ischemic muscle becomes a medium for anaerobic bacterial growth and toxin production. While gas gangrene is an uncommon complication of trauma resuscitation, the underlying principle applies broadly: ischemic tissue is vulnerable tissue, and reperfusion is not uniformly beneficial.

The practical implication is that salvage resuscitation does not end with ROSC. The patient that survives the initial intervention faces a period of reperfusion injury, coagulopathy, and inflammatory activation that can be as lethal as the original hemorrhage. The decision to continue resuscitation therefore includes a commitment to the post-resuscitation care that follows. A clinician who cannot provide that care, or an owner who cannot accept that trajectory, may reasonably choose to stop earlier instead of later.

Defining Futility in Veterinary Trauma

Futility is not a single threshold but a probability assessment. The clinician estimates the likelihood that continued intervention will achieve a meaningful outcome, defined as survival to discharge with acceptable quality of life. This estimate incorporates the arrest duration, the arrest rhythm, the injury pattern, the response to initial resuscitation, and the available resources.

The RECOVER Initiative guidelines provide a structured approach to arrest management but do not define futility thresholds for trauma specifically. The clinician must therefore integrate the guidelines with trauma-specific evidence and clinical judgment. The key distinction is between the patient that has not yet arrested and the patient that has. In the pre-arrest patient, continued aggressive resuscitation is generally warranted while reversible causes are addressed. In the arrested patient, the duration of arrest and the rhythm on presentation become the dominant prognostic factors.

The euthanasia decision is not a failure of resuscitation. It is a legitimate therapeutic endpoint when the probability of meaningful survival is negligible or when the owner's goals for the patient cannot be met. The American Veterinary Medical Association practice resources address the professional obligations surrounding end-of-life decisions, including the responsibility to relieve suffering when continued intervention cannot achieve a reasonable outcome. The clinician's duty is to provide an honest prognosis, to recommend against futile interventions, and to support the owner through the decision process.

Decision Point 1: The First 10 Minutes

The salvage resuscitation decision begins with a structured assessment that separates reversible from irreversible causes of traumatic cardiac arrest. The RECOVER initiative guidelines provide the framework for basic and advanced life support, but they do not address when resuscitation should be withheld or terminated in trauma patients. That determination rests on the clinician's integration of arrest characteriztics, injury pattern, and available resources.

Three questions must be answered within the first 10 minutes of resuscitation. First, is there a reversible mechanical cause such as pericardial tamponade, tension pneumothorax, or exsanguinating hemorrhage from a compressible site? Second, does the patient have any electrical cardiac activity on the monitor, even if pulseless? Third, can the identified cause be addressed with the equipment and personnel currently available in the hospital?

Pulseless electrical activity (PEA) carries a different prognosis than asystole in traumatic arrest. In the translational swine model of hemorrhage-induced traumatic cardiac arrest, animals with sustained systolic blood pressure below 30 mmHg progressed to electrocardiographic asystole, and return of spontaneous circulation required aortic occlusion combined with oxygenated perfusion instead of standard resuscitation alone. This distinction matters clinically. A dog with PEA and a tension pneumothorax has a plausible path to survival. A dog with asystole after 15 minutes of CPR and an open hemithorax does not.

Decision Point 2: The 15-Minute Reassessment

At 15 minutes, the resuscitation team must answer a second set of questions. Has the patient demonstrated any return of spontaneous circulation, even transiently? Has end-tidal carbon dioxide (EtCO₂) improved from initial values? Has the identified hemorrhage source been controlled?

The RECOVER guidelines emphasize that EtCO₂ below 10 mmHg after 20 minutes of CPR predicts failure to achieve return of spontaneous circulation in non-traumatic arrest. The same threshold has not been validated in trauma, but the physiologic principle transfers. A trauma patient with EtCO₂ persistently below 10 mmHg despite effective chest compressions, hemorrhage control attempts, and volume resuscitation has exhausted the reversible causes that can be addressed in the field or emergency room.

The reassessment should also include a search for missed injuries. A patient who initially appeared to have isolated thoracic trauma may have developed abdominal distension from a splenic or hepatic laceration. The decision to continue resuscitation depends on whether the newly identified injury is addressable. Non-compressible torso hemorrhage, particularly from the liver or retroperitoneal vessels, cannot be controlled with direct pressure. Resuscitative endovascular balloon occlusion of the aorta (REBOA) offers a method of temporary hemorrhage control and blood pressure augmentation cranial to the balloon, but it requires specific equipment and training that many small animal practices do not possess. The review by Hoareau and colleagues outlines the potential translation of REBOA to veterinary patients, but it also acknowledges the limitations of ischemia-reperfusion injury to caudal tissue beds and the technical challenges of placement.

Decision Point 3: The Ethical Checkpoint

The ethical checkpoint occurs when the clinical team has determined that further intervention cannot restore spontaneous circulation or meaningful neurologic function. This determination should be made by the attending clinician, communicated clearly to the nursing staff and owners, and documented in the medical record.

The AVMA practice resources provide guidance on professional obligations regarding patient welfare and client communication, but they do not prescribe specific criteria for terminating resuscitation in trauma. The decision rests on the clinician's judgment, informed by the patient's arrest characteriztics, the injuries identified, and the resources available.

Three conditions must be met before terminating resuscitation. The patient must have received adequate CPR per RECOVER guidelines, including appropriate ventilation, chest compressions, and vasopressor administration. Reversible causes must have been systematically sought and either treated or ruled out. And the patient must show no signs of life, including spontaneous ventilation, pupillary light response, or organized cardiac rhythm, after 15 to 20 minutes of resuscitative effort.

The owner communication at this point should be direct and compassionate. The clinician should state that resuscitation has been attempted, that the injuries were not survivable, and that further efforts would not restore the patient to consciousness or comfort. The decision to continue or stop should be framed as a medical determination, not a financial one, although cost may be a factor in how far the initial resuscitation proceeds.

Monitoring Parameters That Change the Decision

Technique Selection: REBOA, Thoracotomy, or Neither

Resuscitative thoracotomy in veterinary patients is rarely performed and has no published survival data in dogs or cats. The procedure carries significant risks, including iatrogenic lung laceration, hemorrhage from the internal thoracic vessels, and contamination of the thoracic cavity. It should be reserved for patients with witnessed arrest, suspected pericardial tamponade or tension pneumothorax, and a reversible cause that can be addressed within minutes.

REBOA offers a less invasive alternative for hemorrhage control in patients with non-compressible torso hemorrhage and residual cardiac activity. The technique requires arterial access, typically via the femoral artery, and fluoroscopic or landmark-based placement of the balloon catheter. Zone 1 occlusion, at the thoracic aorta, controls subdiaphragmatic hemorrhage but exposes the kidneys, intestines, and hindlimbs to ischemia. The maximum safe occlusion time in humans is generally considered 30 to 60 minutes, and the same limitation applies to veterinary patients. The review by Hoareau and colleagues describes the step-by-step approach to REBOA implementation and discusses the common challenges observed in translational large animal studies.

The decision between REBOA, thoracotomy, and continued medical resuscitation depends on three factors: the patient's residual cardiac activity, the suspected source of hemorrhage, and the equipment available. A patient with PEA and suspected abdominal hemorrhage may benefit from REBOA if the catheter and training are available. A patient with asystole and suspected pericardial tamponade may benefit from thoracotomy if performed within minutes of arrest. A patient with asystole and suspected major vascular disruption will not survive regardless of the intervention chosen.

Documentation and Communication

The medical record should document the time of arrest, the initial rhythm, the interventions performed, the monitoring parameters obtained, and the time of termination. The record should also note the owner communication, including the information provided and the owner's response. This documentation serves both medical and legal purposes. It provides a clear account of the resuscitation effort for future reference and demonstrates that the decision to terminate was based on clinical criteria instead of arbitrary factors.

The owner communication should occur as soon as the decision to terminate is made. The attending clinician should speak with the owner directly, either in person or by telephone, and should provide a clear explanation of the patient's injuries, the resuscitation efforts, and the reasons for termination. The clinician should also address the owner's questions about whether anything else could have been done. The answer should be honest: in cases where the injuries were not survivable, further intervention would not have changed the outcome.

Recognized Complications and Early Detection

Salvage resuscitation fails in predictable patterns. The most consequential is reperfusion injury after aortic occlusion. When the balloon is deflated or the aortic clamp released, ischemic caudal tissues are reperfused with oxygenated blood, generating reactive oxygen species, activating neutrophils, and releasing potassium, lactate, and hydrogen ions into the central circulation. The resulting hyperkalemia, metabolic acidosis, and myocardial depression can precipitate refractory arrhythmias or recurrent arrest. Early detection requires continuous ECG and capnography during and immediately after deflation, with arterial blood gas and electrolyte measurement within minutes of reperfusion. A sudden rise in end-tidal carbon dioxide followed by ventricular arrhythmias or a falling blood pressure should trigger immediate reassessment of perfusion status instead of being dismissed as a transient event.

Coagulopathy is a second major failure mode. Trauma patients arrive with variable degrees of consumptive coagulopathy, and aggressive crystalloid resuscitation dilutes remaining clotting factors. The damage control approach limits this by using small-volume resuscitation and early blood products, but even balanced protocols can fail when hemorrhage is uncontrolled. Detection relies on serial point-of-care coagulation testing, including viscoelastic monitoring where available, and on clinical observation of bleeding from catheter sites, wounds, or body cavities. Progressive oozing from venipuncture sites or the surgical field indicates that the coagulopathy is advancing faster than replacement can correct it.

The third failure mode is ongoing hemorrhage despite aortic occlusion. REBOA controls subdiaphragmatic bleeding but does nothing for thoracic hemorrhage, and it does not stop venous bleeding or bleeding from vessels that have retracted into the pelvic canal. A patient who remains hypotensive with a rising lactate despite adequate occlusion has either incomplete occlusion, a thoracic source, or a source cranial to the balloon. Detection requires point-of-care ultrasound to reassess the thoracic and abdominal cavities, and a careful check of balloon position and inflation pressure.

Common Errors and Corrective Actions

Less experienced clinicians often mistake transient improvement for durable recovery. A patient who brightens briefly after the first fluid bolus or after aortic occlusion may still have an unsalvageable injury burden. The corrective action is to track trends, not single values. A single normal blood pressure reading means little if the heart rate is climbing and the lactate is rising.

A second error is delaying the futility decision while pursuing additional diagnostics. When a patient has been in arrest for more than 10 minutes without a compressible cause, further imaging rarely changes the outcome. The RECOVER guidelines provide structured decision points for continuing or stopping CPR, and the same discipline should apply to salvage resuscitation. Set a time limit at the outset, communicate it to the team, and reassess at that limit instead of drifting into open-ended resuscitation.

A third error is under-resuscitating the cranial compartment during aortic occlusion. Occlusion of the thoracic aorta improves perfusion to the heart and brain, but those tissues still require oxygen-carrying capacity. A patient who achieves return of spontaneous circulation with a low hematocrit may sustain further ischemic injury. The corrective action is to treat aortic occlusion as a bridge to definitive hemorrhage control, not as a substitute for blood product administration.

Limitations of the Evidence

The evidence base for salvage resuscitation in veterinary patients is thin. Most of what is known about REBOA and resuscitative thoracotomy comes from human trauma registries and translational large animal studies. The swine model of hemorrhage-induced traumatic cardiac arrest demonstrated that selective aortic arch perfusion with an oxygen-carrying perfusate achieved return of spontaneous circulation more effectively than REBOA alone, but this model does not replicate the full spectrum of injuries seen in clinical veterinary patients. The veterinary literature on REBOA remains largely descriptive, and the RECOVER guidelines acknowledge that many recommendations are extrapolated from human medicine or based on expert opinion instead of controlled trials.

Expert opinion still differs on several points. Some clinicians advocate for resuscitative thoracotomy in any patient with witnessed arrest and a compressible cause, while others limit the procedure to patients with pericardial effusion or penetrating thoracic trauma. The role of open chest CPR versus closed chest CPR in the trauma patient remains contested. The duration of aortic occlusion that is safe in dogs and cats is unknown, and the trade-off between hemorrhage control and visceral ischemia cannot be precisely quantified. These uncertainties should be acknowledged honestly in discussions with owners.

Referral, Consultation, and Reporting

Referral is appropriate when the patient is hemodynamically stable enough to transport and the receiving facility has capabilities that the current clinic lacks. These capabilities include advanced imaging, interventional radiology, or a surgeon experienced in damage control techniques. A patient with suspected non-compressible torso hemorrhage that has been temporarily stabilized with aortic occlusion should be moved to a facility where definitive hemorrhage control can be achieved, provided transport time is short and the occlusion time has not already exceeded a safe window.

Specialist consultation is warranted before attempting REBOA in a patient with known aortic disease, in any patient where the anatomy is uncertain, and in cases where the clinician has not performed the procedure recently. The review of REBOA applications in veterinary emergency and critical care describes the technical challenges and the importance of appropriate patient selection. A veterinary emergency and critical care specialist can provide guidance on patient selection and technique even if they cannot be physically present.

Laboratory involvement is indicated when the clinical picture suggests a coagulopathy that is not explained by trauma alone, such as a patient with pre-existing liver disease or a suspected toxin exposure. The MSD Veterinary Manual provides species-specific guidance on coagulation testing and interpretation. Regulatory reporting is rarely required for trauma cases, but veterinarians should be aware of their obligations under local animal welfare statutes, and the AVMA practice resources and WOAH terrestrial animal health standards provide frameworks for professional conduct and reporting where applicable.

Frequently Asked Questions

How Do I Decide When to Stop Resuscitation When My Clinic Lacks REBOA or Advanced Monitoring?

The absence of endovascular tools does not change the physiology. Apply the same time-based decision points using physical examination and basic monitoring. If spontaneous circulation has not returned after 10 to 15 minutes of appropriate CPR and hemorrhage control, survival is unlikely regardless of technique. The RECOVER guidelines provide the core CPR framework that should anchor your efforts. Without aortic occlusion capability, non-compressible torso hemorrhage carries a grave prognosis, and you should communicate this clearly to the owner early. Document the resources available, the interventions performed, and the physiological response at each decision point. Your ethical obligation is to avoid prolonged, futile efforts when the available tools cannot address the underlying injury pattern.

What Do I Tell an Owner Who Wants "Everything Done" for a Moribund Trauma Patient?

Frame the conversation around probability and suffering, not personal preference. Explain that severe trauma with cardiac arrest carries a very low survival rate even with aggressive intervention, and that the interventions themselves are painful and invasive. Use the term "salvage" deliberately and describe what it means: temporary stabilization aimed at reaching surgery, not a guarantee of recovery. Offer a time-limited trial with explicit endpoints, such as return of spontaneous circulation within 15 minutes. The AVMA practice resources offer guidance on end-of-life communication and shared decision-making. If the owner insists on continued efforts beyond reasonable futility thresholds, document their informed consent and your professional recommendation against further intervention.

How Does the Decision Differ in Cats Compared with Dogs?

Feline trauma patients present unique challenges. Cats are more prone to hypothermia and bradycardia during resuscitation, and their smaller size limits the utility of some endovascular techniques. Thoracic wall compliance differs, and effective compressions require a higher rate with a narrower compression depth. The RECOVER guidelines address species-specific CPR modifications. Feline patients with traumatic cardiac arrest often have a poorer prognosis than dogs with comparable injuries, partly due to the frequency of high-impact thoracic trauma. Reassessment intervals should remain the same, but you should lower your threshold for declaring futility in cats that remain asystolic after 10 minutes of appropriate effort. Communicate this species-specific prognosis to owners during the resuscitation.

What Are the Financial and Resource Limits I Should Consider Before Starting Salvage Resuscitation?

Salvage resuscitation consumes staff, time, blood products, and operating room availability. Before initiating, estimate the total cost of the resuscitation, immediate surgery, and postoperative critical care. If the practice cannot provide definitive hemorrhage control within the expected survival window, starting aggressive salvage may be inappropriate. Discuss a financial ceiling with the owner during the initial consent process, and define what interventions are included. The AAHA/AAFP fluid therapy guidelines emphasize planning and resource allocation in emergency settings. If transfer to a referral center is possible, weigh the stabilization time against transport time. A patient that cannot be stabilized for transport has a poor prognosis at a primary care facility without surgical capability.

How Should I Document a Futility Decision to Protect Myself and My Team?

Document the timeline, the physiological parameters at each decision point, and the specific criteria used to declare futility. Record the owner communication, including their questions and your responses. Note the absence of spontaneous circulation, the rhythm on the monitor, the end-tidal carbon dioxide trend if available, and the response to each intervention. State explicitly that the decision was based on published survival data and the patient's injury pattern. The MSD Veterinary Manual provides reference material on trauma prognosis that can support your documentation. Include the names of all team members present and their roles. A contemporaneous, objective record demonstrates that the decision was clinical, not emotional or financial.

Can I Use Resuscitative Thoracotomy in Practice, or Is It Only for Referral Hospitals?

Resuscitative thoracotomy is a high-skill, high-complication procedure that requires surgical proficiency and immediate postoperative resources. It is appropriate only when penetrating thoracic trauma or pericardial tamponade is suspected and when the patient has witnessed arrest with recent cardiac activity. The procedure can be performed in general practice if the clinician has the training and the facility can provide immediate surgical aftercare. However, the evidence from human trauma literature, including work on aortic occlusion and traumatic cardiac arrest, suggests that survival is rare even under ideal conditions. If you lack the case volume to maintain the skill, referral is safer for the patient and the team. Consider REBOA as a less invasive alternative where training and equipment are available.

Related Clinical & Scientific Guides

• Toxicology in Emergency Practice: Common Poisons and Diagnostic Approach
• Veterinary Cardiopulmonary Resuscitation: Post-Cardiac Arrest Care
• Fluid Therapy Guidelines for Dogs and Cats: A Practical Update

References and Further Reading

• Resuscitative Endovascular Balloon Occlusion of the Aorta: Review of the Literature and Applications to Veterinary Emergency and Critical Care.. 2019.
• A comparison of Selective Aortic Arch Perfusion and Resuscitative Endovascular Balloon Occlusion of the Aorta for the management of hemorrhage-induced traumatic cardiac arrest: A translational model in large swine.. 2017.
• Clostridial Myonecrosis: A Comprehensive Review of Toxin Pathophysiology and Management Strategies.. 2024.
• Total laparoscopic radical hysterectomy for cervical cancer in prolapsed uterus.. 2010.
• RECOVER Initiative Veterinary CPR Guidelines. Veterinary Emergency and Critical Care Society.
• AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats. AAHA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.
• WOAH Terrestrial Animal Health Code. WOAH.

Related Articles

• Veterinary Shock: Fluid Resuscitation Strategies
• Veterinary Trauma: Secondary Survey and Diagnostic Imaging
• Oxygen Concentrators for Veterinary Clinics: Selection and Use
• Trauma Triage and Primary Survey in Small Animals
• Veterinary Trauma: Primary Survey and Immediate Stabilization

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.